Our mission is to improve diabetics quality of life by becoming the leading supplier of miniature insulin injection devices, introducing an artificial intelligence based diabetes management system and
researching novel techniques to reverse diabetes.
Diabetes is a chronic condition associated with abnormally high levels of sugar (glucose) in the blood. Insulin produced by the pancreas lowers blood glucose. Absence or insufficient production of insulin or an inability of the body to properly use insulin causes diabetes.
Estimated 500 million people globally suffer from diabetes, the top non-communicable disease on the planet.
Approximately 3 million people die every year due to diabetes
It is estimated that 1 in every 11 people suffer from diabetes or diabetes related illnesses
No focus on cures
Most companies focus on managing and not reversing diabetes
Many existing insulin delivery devices are expensive, beyond the reach of many
There are no small insulin delivery devices on the market today and no non-invasive, continuous and low cost blood sugar meters
Doctors and patients do not collaborate, diabetics self-test data is not readily available to the doctor
Diabetes care gap
Growing number of patients not matched by an increasing number of medical personnel will lead to increased ill health and a higher mortality rate
MinipenTM is our miniature therapeutic delivery device designed for self-injection insulin and many other therapeutics
Advanced blood glucose testing (using our own sensor technology)
Diabetes Management SystemTM
Portal and mobile monitoring to improve collaboration and the control of diabetes
By introducing clinic and digital test labs that support patients using our Diabetes Management Portal and mobile technology
Focus on cures
Education to help reverse diabetes. We will invest at least 20% of our research into the reversal of diabetes (all types)